{"entity":{"type":"insider","cik":"0001772518","url":"/insider/0001772518","json_url":"/insider/0001772518.json","name":"Ridloff Elena","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":13,"first":"2019-12-11","last":"2026-05-11","span_basis":"filed_date"},"name_variants":[{"name":"Ridloff Elena","source":"filing","n_filings":13,"first_seen":"2019-12-11","last_seen":"2026-05-11"}],"transactions":[{"id":5907576,"accession":"0001193125-26-217041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-217041","line_url":"/filing/0001193125-26-217041#line-2","is_derivative":false,"issuer_cik":"0001772518","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001772518","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":87.0,"price_display":"87.00","price_state":"stated","total_value":261000.0,"total_display":"261,000.00","total_whole":"261,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-11","scope":"insider"},{"id":6195532,"accession":"0001193125-26-138372","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-26-138372","line_url":"/filing/0001193125-26-138372","is_derivative":false,"issuer_cik":"0001772518","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001772518","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":85.41774782608695,"price_display":"85.42","price_state":"stated","total_value":392921.64,"total_display":"392,921.64","total_whole":"392,922","shares_owned_after":1200.0,"shares_owned_after_display":"1,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-01","scope":"insider","n_lines":2},{"id":6195521,"accession":"0001193125-26-138372","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-138372","line_url":"/filing/0001193125-26-138372#line-2","is_derivative":false,"issuer_cik":"0001772518","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001772518","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7400.0,"shares_display":"7,400","price_per_share":85.3701,"price_display":"85.37","price_state":"stated","total_value":631738.74,"total_display":"631,738.74","total_whole":"631,739","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-01","scope":"insider"},{"id":4398465,"accession":"0002036042-25-000053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002036042-25-000053","line_url":"/filing/0002036042-25-000053#line-2","is_derivative":false,"issuer_cik":"0001772518","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001772518","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (CFO & Head of Corp. Dev)","role_mark":"O","role_mark_label":"Officer (CFO & Head of Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Head of Corp. Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8836.0,"shares_display":"8,836","price_per_share":25.08,"price_display":"25.08","price_state":"stated","total_value":221606.88,"total_display":"221,606.88","total_whole":"221,607","shares_owned_after":38532.0,"shares_owned_after_display":"38,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-03","scope":"insider"},{"id":4398460,"accession":"0002036042-25-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002036042-25-000053","line_url":"/filing/0002036042-25-000053#line-1","is_derivative":false,"issuer_cik":"0001772518","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001772518","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (CFO & Head of Corp. Dev)","role_mark":"O","role_mark_label":"Officer (CFO & Head of Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Head of Corp. Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":748.0,"shares_display":"748","price_per_share":25.18,"price_display":"25.18","price_state":"stated","total_value":18834.64,"total_display":"18,834.64","total_whole":"18,835","shares_owned_after":47368.0,"shares_owned_after_display":"47,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-29","filed_date":"2025-09-03","scope":"insider"},{"id":4188748,"accession":"0002036042-25-000050","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002036042-25-000050","line_url":"/filing/0002036042-25-000050#line-3","is_derivative":false,"issuer_cik":"0001772518","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001772518","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (CFO & Head of Corp. Dev)","role_mark":"O","role_mark_label":"Officer (CFO & Head of Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Head of Corp. Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16098.0,"shares_display":"16,098","price_per_share":25.97,"price_display":"25.97","price_state":"stated","total_value":418065.06,"total_display":"418,065.06","total_whole":"418,065","shares_owned_after":48116.0,"shares_owned_after_display":"48,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-28","filed_date":"2025-08-28","scope":"insider"},{"id":4188746,"accession":"0002036042-25-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002036042-25-000050","line_url":"/filing/0002036042-25-000050#line-2","is_derivative":false,"issuer_cik":"0001772518","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001772518","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (CFO & Head of Corp. Dev)","role_mark":"O","role_mark_label":"Officer (CFO & Head of Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Head of Corp. Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3618.0,"shares_display":"3,618","price_per_share":25.1,"price_display":"25.10","price_state":"stated","total_value":90811.8,"total_display":"90,811.80","total_whole":"90,812","shares_owned_after":64214.0,"shares_owned_after_display":"64,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-27","filed_date":"2025-08-28","scope":"insider"},{"id":4188741,"accession":"0002036042-25-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002036042-25-000050","line_url":"/filing/0002036042-25-000050#line-1","is_derivative":false,"issuer_cik":"0001772518","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001772518","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (CFO & Head of Corp. Dev)","role_mark":"O","role_mark_label":"Officer (CFO & Head of Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Head of Corp. Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":25.13,"price_display":"25.13","price_state":"stated","total_value":92981.0,"total_display":"92,981.00","total_whole":"92,981","shares_owned_after":67832.0,"shares_owned_after_display":"67,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-28","scope":"insider"},{"id":4892922,"accession":"0001482981-25-000143","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001482981-25-000143","line_url":"/filing/0001482981-25-000143#line-2","is_derivative":false,"issuer_cik":"0001772518","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001772518","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (CFO & Head of Corp. Dev)","role_mark":"O","role_mark_label":"Officer (CFO & Head of Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Head of Corp. Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":22.69,"price_display":"22.69","price_state":"stated","total_value":397075.0,"total_display":"397,075.00","total_whole":"397,075","shares_owned_after":71532.0,"shares_owned_after_display":"71,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-20","filed_date":"2025-08-21","scope":"insider"},{"id":4892920,"accession":"0001482981-25-000143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001482981-25-000143","line_url":"/filing/0001482981-25-000143#line-1","is_derivative":false,"issuer_cik":"0001772518","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001772518","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (CFO & Head of Corp. Dev)","role_mark":"O","role_mark_label":"Officer (CFO & Head of Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Head of Corp. Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34500.0,"shares_display":"34,500","price_per_share":21.08,"price_display":"21.08","price_state":"stated","total_value":727260.0,"total_display":"727,260.00","total_whole":"727,260","shares_owned_after":89032.0,"shares_owned_after_display":"89,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-19","filed_date":"2025-08-21","scope":"insider"},{"id":4873146,"accession":"0000950170-25-084893","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-084893","line_url":"/filing/0000950170-25-084893#line-2","is_derivative":false,"issuer_cik":"0001772518","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001772518","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-11","filed_date":"2025-06-11","scope":"insider"},{"id":4132478,"accession":"0000950170-25-081200","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-081200","line_url":"/filing/0000950170-25-081200","is_derivative":false,"issuer_cik":"0001772518","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001772518","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":46.1,"price_display":"46.10","price_state":"stated","total_value":553200.0,"total_display":"553,200.00","total_whole":"553,200","shares_owned_after":4800.0,"shares_owned_after_display":"4,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-03","scope":"insider","n_lines":2},{"id":4424136,"accession":"0001209191-21-029359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-029359","line_url":"/filing/0001209191-21-029359#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (EVP and CFO)","role_mark":"O","role_mark_label":"Officer (EVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1032.0,"shares_display":"1,032","price_per_share":20.33,"price_display":"20.33","price_state":"stated","total_value":20980.56,"total_display":"20,980.56","total_whole":"20,981","shares_owned_after":10553.0,"shares_owned_after_display":"10,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-30","filed_date":"2021-04-30","scope":"insider"},{"id":4553548,"accession":"0001209191-21-008661","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-008661","line_url":"/filing/0001209191-21-008661#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (EVP and CFO)","role_mark":"O","role_mark_label":"Officer (EVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2051.0,"shares_display":"2,051","price_per_share":50.61,"price_display":"50.61","price_state":"stated","total_value":103801.11,"total_display":"103,801.11","total_whole":"103,801","shares_owned_after":8340.0,"shares_owned_after_display":"8,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-08","scope":"insider"},{"id":4715309,"accession":"0001209191-21-002832","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-002832","line_url":"/filing/0001209191-21-002832#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (EVP and CFO)","role_mark":"O","role_mark_label":"Officer (EVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1016.0,"shares_display":"1,016","price_per_share":53.34,"price_display":"53.34","price_state":"stated","total_value":54193.44,"total_display":"54,193.44","total_whole":"54,193","shares_owned_after":3901.0,"shares_owned_after_display":"3,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-08","scope":"insider"},{"id":2252105,"accession":"0001209191-20-055043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-055043","line_url":"/filing/0001209191-20-055043#line-1","is_derivative":false,"issuer_cik":"0001741830","issuer_name":"Kronos Bio, Inc.","issuer_ticker":"KRON","issuer_name_source":null,"issuer_url":"/issuer/0001741830","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2630.0,"shares_display":"2,630","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":49970.0,"total_display":"49,970.00","total_whole":"49,970","shares_owned_after":2630.0,"shares_owned_after_display":"2,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-16","scope":"insider"},{"id":2336397,"accession":"0001209191-20-026615","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-026615","line_url":"/filing/0001209191-20-026615#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (EVP and CFO)","role_mark":"O","role_mark_label":"Officer (EVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1050.0,"shares_display":"1,050","price_per_share":49.22,"price_display":"49.22","price_state":"stated","total_value":51681.0,"total_display":"51,681.00","total_whole":"51,681","shares_owned_after":2195.0,"shares_owned_after_display":"2,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-30","filed_date":"2020-05-01","scope":"insider"},{"id":2336392,"accession":"0001209191-20-026615","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-026615","line_url":"/filing/0001209191-20-026615#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (EVP and CFO)","role_mark":"O","role_mark_label":"Officer (EVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.7353,"price_display":"50.74","price_state":"stated","total_value":507353.0,"total_display":"507,353.00","total_whole":"507,353","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-29","filed_date":"2020-05-01","scope":"insider"},{"id":8103515,"accession":"0001209191-19-060100","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-060100","line_url":"/filing/0001209191-19-060100","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001772518","owner_name":"Ridloff Elena","owner_display_name":"Ridloff Elena","owner_url":"/insider/0001772518","role":"Officer (EVP and CFO)","role_mark":"O","role_mark_label":"Officer (EVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":49.662595777777774,"price_display":"49.66","price_state":"stated","total_value":1787853.448,"total_display":"1,787,853.45","total_whole":"1,787,853","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001815442","name":"Kymera Therapeutics, Inc.","url":"/issuer/0001815442","role":"Director","n_filings":4,"first_seen":"2025-06-03","last_seen":"2026-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0002036042","name":"Sionna Therapeutics, Inc.","url":"/issuer/0002036042","role":"Officer (CFO & Head of Corp. Dev)","n_filings":3,"first_seen":"2025-08-21","last_seen":"2025-09-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Officer (EVP and CFO)","n_filings":5,"first_seen":"2019-12-11","last_seen":"2021-04-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001741830","name":"Kronos Bio, Inc.","url":"/issuer/0001741830","role":"Director","n_filings":1,"first_seen":"2020-10-16","last_seen":"2020-10-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001772518","retrieved_at":"2026-08-27T14:03:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}